Active JNJ Drug

DRUG2 trials

Sponsors

Chengappa, K.N. Roy, MD, K.N. Roy Chengappa

Conditions

Smoking Cessation

Phase 2

Test of Novel Drug for Smoking Cessation

CompletedNCT02217527

Chengappa, K.N. Roy, MDSmoking Cessation

Start: 2014-11-30End: 2018-01-31Updated: 2018-08-15

Novel Smoking Cessation Drug for Schizophrenia

CompletedNCT02230384

K.N. Roy ChengappaSmoking Cessation

Start: 2014-09-30End: 2017-03-09Updated: 2019-04-02